Detalhe da pesquisa
1.
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.
Cell
; 173(3): 611-623.e17, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656891
2.
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Cell
; 173(3): 595-610.e11, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656894
3.
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Cell
; 173(3): 581-594.e12, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656895
4.
Pervasive chromosomal instability and karyotype order in tumour evolution.
Nature
; 587(7832): 126-132, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32879494
5.
Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer.
BJU Int
; 128 Suppl 1: 18-26, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622543
6.
New survival standards for advanced melanoma.
Br J Cancer
; 122(9): 1275-1276, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32063602
7.
Hitting the sweet spot: optimal use of corticosteroids for immune checkpoint inhibitor side-effects.
Lancet Oncol
; 23(9): 1123-1124, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055300
8.
Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series.
Cancer Immunol Immunother
; 66(1): 113-117, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27838762
9.
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management.
Pharmaceut Med
; 38(1): 25-38, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194017
10.
Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
Curr Oncol
; 30(1): 923-937, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661719
11.
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review.
Ther Adv Med Oncol
; 15: 17588359231177018, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37323189
12.
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Expert Rev Pharmacoecon Outcomes Res
; 23(2): 231-239, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541133
13.
Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.
Front Endocrinol (Lausanne)
; 14: 1295865, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38093958
14.
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.
Cancer Discov
; 13(6): 1364-1385, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36977461
15.
The Genetic Evolution of Metastasis.
Cancer Res
; 82(10): 1849-1857, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476646
16.
Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer.
BJUI Compass
; 3(3): 205-213, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35492221
17.
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis.
Asia Pac J Clin Oncol
; 18(6): 642-649, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098653
18.
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series.
Melanoma Res
; 32(6): 451-459, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164923
19.
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.
Eur Urol
; 81(3): 253-262, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34493414
20.
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
Data Brief
; 45: 108649, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36426082